Heather Onorati is a contributing writer for Dermatology Times.
Dermatologist turns sterilized wraps into face masks with high filter efficiencyMay 18th 2020
A third-year resident in the department of dermatology at the University of California, Irvine has kicked off a passion project turning discarded sterilization wrap into face masks with a high filter efficiency. She hopes these will fill a need as well as reserve N95 masks and surgical masks for those procedures that they are designated.
COVID-19: Experts discuss virulence, potential treatments, controversiesMarch 31st 2020
Governments and the scientific community are racing to identify new and existing drugs that might help flatten the curve and save lives. Read from experts as they discuss the latest news and research surrounding possible treatments for COVID-19.
Experts advise caution over early, emerging treatmentsMarch 25th 2020
Experts sent a letter to the White House Coronavirus Task Force March 24, outlining concerns about a growing shortage of medications required for managing patients with lupus and rheumatoid arthritis after President Donald Trump said in a March 19 press conference that the anti-malaria drug hydroxychloroquine could treat COVID-19.
Malaria drug hydroxychloroquine may treat COVID-19March 20th 2020
As the number of patients infected with COVID-19 continues to rise, several experts are relaying data they say may save lives and change the course of this pandemic. According to Drs. George Martin, Ted Rosen, Sheila Fallon-Friedlander, Albert Yan, and James Treat, recent data provides evidence of the use of HCQ, its dosing, as well as epidemiology insights that will serve all healthcare practitioners in the fight against the novel coronavirus, COVID-19.
Phase 3 results show risankizumab outperforms secukinumabJanuary 17th 2020
Risankizumab (SKYRIZI, AbbVie), outperformed secukinumab (Cosentyx, Novartis) in a head-to-head phase 3 study comparing the two treatments in adult patients with moderate to severe plaque psoriasis, according to data released by the company Jan. 14.
Hackathon winners explore precision medicineNovember 14th 2019
By the end of a three-day weekend, five of the teams at Hacking Dermatology's 2019 Hackathon walked away with $5,000 each. Learn more about the collaboration that took place and the solutions each team developed to solve pressing problem areas in dermatology.
More highlights from MauiDerm 2014January 29th 2014
New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.